From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
PDA vs PWB | Total | Agreement | Low discordance | High discordance | ||
---|---|---|---|---|---|---|
Median (ICR) | ≤+/-1 | PDA >1-3 worse | PWB >1-3 worse | PDA >3 worse | PWB >3 worse | |
Female gender, n (%) | 5956 (66.2) | 4452 (65.4) | 515 (70.3) | 477 (69.1) | 274 (64.9) | 238 (69.8) |
Age at visit (years) | 11.6 (7.7; 14.8) | 11.5 (7.6; 14.8) | 11.3 (7.6; 14.8) | 12.7 (8.7; 15.6) | 10.8 (7.1; 14.9) | 12.6 (9.3; 15.4) |
Disease duration | 4.0 (1.8; 7.0) | 4.0 (1.9; 7.0) | 3.5 (1.3; 6.7) | 4.0 (1.8; 7.4) | 3.5 (1.3; 6.6) | 3.9 (1.8; 7.2) |
Active Joints | 0 (0; 2) | 0 (0; 1) | 1 (0; 3) | 0 (0; 2) | 1 (0; 2) | 0 (0; 2) |
Morning stiffness, n (%) | 2923 (33.7) | 1875 (28.6) | 400 (56.2) | 301 (45.2) | 222 (54.4) | 125 (38.1) |
Stiffness duration (min) | 15-30 | 15-30 | 15-30 | 15-30 | 15-30 | <15 |
Pain score | 1.0 (0; 3.5) | 0.5 (0; 2.5) | 3.5 (1.5; 5.5) | 2.0 (0.5; 5.0) | 2.5 (0.0; 5.0) | 2.0 (0.0; 5.0) |
Quality of Life | 3 (1; 7) | 2 (0; 6) | 5 (3; 9) | 7 (4; 11) | 4 (2; 8) | 8 (4; 11) |